{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:12:44Z","timestamp":1791832364601,"version":"4.3.4"},"reference-count":21,"publisher":"IMR Press","issue":"5","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Background: Iron deficiency leads to health problems. Conversely, iron overload induces the generation of reactive oxygen species and health problems. Body iron status contributes to the development of various diseases, including aortic disease. Indeed, several clinical studies have reported that iron status can be linked to the pathogenesis of aortic disease. At the cellular level, iron uptake is regulated by the cellular iron transporter, transferrin receptor 1, while systemic iron homeostasis is regulated by hepcidin. As body iron status is regulated to maintain cellular and systemic iron homeostasis, iron metabolism in aortic disease is puzzling and not well understood. Methods: Perspective and short communication. Conclusions: This review provides an overview of the relevant research investigating the association between cellular iron metabolism and aortic disease.<\/jats:p>","DOI":"10.31083\/j.rcm2305169","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T07:39:27Z","timestamp":1653032367000},"source":"Crossref","is-referenced-by-count":6,"title":["Focus on Cellular Iron Metabolism in Aortic Disease"],"prefix":"10.31083","volume":"23","author":[{"given":"Yoshiro","family":"Naito","sequence":"first","affiliation":[{"name":"Department of Cardiovascular and Renal Medicine, Hyogo Medical University, 663-8501 Nishinomiya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Ishihara","sequence":"first","affiliation":[{"name":"Department of Cardiovascular and Renal Medicine, Hyogo Medical University, 663-8501 Nishinomiya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Koleini N, Shapiro JS, Geier J, Ardehali H. Ironing out mechanisms of iron homeostasis and disorders of iron deficiency. Journal of Clinical Investigation. 2021; 131: e148671.","DOI":"10.1172\/JCI148671"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Moore Heslin A, O\u2019Donnell A, Buffini M, Nugent AP, Walton J, Flynn A, et al. Risk of iron overload in obesity and implications in metabolic health. Nutrients. 2021; 13: 1539.","DOI":"10.3390\/nu13051539"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Real JM, Manco M. Effects of iron overload on chronic metabolic diseases. The Lancet Diabetes and Endocrinology. 2014; 2: 513\u2013526.","DOI":"10.1016\/S2213-8587(13)70174-8"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Salonen JT, Nyyss\u00f6nen K, Korpela H, Tuomilehto J, Sepp\u00e4nen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992; 86: 803\u2013811.","DOI":"10.1161\/01.CIR.86.3.803"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body Iron Stores and the Risk of Carotid Atherosclerosis. Circulation. 1997; 96: 3300\u20133307.","DOI":"10.1161\/01.CIR.96.10.3300"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Sung KC, Kang SM, Cho EJ, Park JB, Wild SH, Byrne CD. Ferritin is Independently Associated with the Presence of Coronary Artery Calcium in 12,033 Men. Arteriosclerosis, Thrombosis, and Vascular Biology. 2012; 32: 2525\u20132530.","DOI":"10.1161\/ATVBAHA.112.253088"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JF, et al. Iron Chelation Improves Endothelial Function in Patients with Coronary Artery Disease. Circulation. 2001; 103: 2799\u20132804.","DOI":"10.1161\/01.CIR.103.23.2799"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Menke A, Fern\u00e1ndez-Real JM, Muntner P, Guallar E. The association of biomarkers of iron status with peripheral arterial disease in us adults. BMC Cardiovascular Disorders. 2009; 9: 34.","DOI":"10.1186\/1471-2261-9-34"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Sullivan JL. Macrophage Iron, Hepcidin, and Atherosclerotic Plaque Stability. Experimental Biology and Medicine. 2007; 232: 1014\u20131020.","DOI":"10.3181\/0703-MR-54"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Gill D, Del Greco MF, Walker AP, Srai SKS, Laffan MA, Minelli C. The Effect of Iron Status on Risk of Coronary Artery Disease: A Mendelian Randomization Study-Brief Report. Arteriosclerosis, Thrombosis, and Vascular Biology. 2017; 37: 1788\u20131792.","DOI":"10.1161\/ATVBAHA.117.309757"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Grammer TB, Kleber ME, Silbernagel G, Pilz S, Scharnagl H, Tomaschitz A, et al. Hemoglobin, iron metabolism and angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health Study). Atherosclerosis. 2014; 236: 292\u2013300.","DOI":"10.1016\/j.atherosclerosis.2014.07.002"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clinical Immunology. 2006; 121: 144\u2013158.","DOI":"10.1016\/j.clim.2006.06.010"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Sawada H, Hao H, Naito Y, Oboshi M, Hirotani S, Mitsuno M, et al. Aortic Iron Overload with Oxidative Stress and Inflammation in Human and Murine Abdominal Aortic Aneurysm. Arteriosclerosis, Thrombosis, and Vascular Biology. 2015; 35: 1507\u20131514.","DOI":"10.1161\/ATVBAHA.115.305586"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Naito Y, Hirotani S, Sawada H, Akahori H, Tsujino T, Masuyama T. Dietary Iron Restriction Prevents Hypertensive Cardiovascular Remodeling in Dahl Salt-Sensitive Rats. Hypertension. 2011; 57: 497\u2013504.","DOI":"10.1161\/HYPERTENSIONAHA.110.159681"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Naito Y, Fujii A, Sawada H, Hirotani S, Iwasaku T, Okuhara Y, et al. Dietary iron restriction prevents further deterioration of renal damage in a chronic kidney disease rat model. Journal of Hypertension. 2013; 31: 1203\u20131213.","DOI":"10.1097\/HJH.0b013e328360381d"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to Tango: Regulation of Mammalian Iron Metabolism. Cell. 2010; 142: 24\u201338.","DOI":"10.1016\/j.cell.2010.06.028"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, et al. The iron exporter ferroportin\/Slc40a1 is essential for iron homeostasis. Cell Metabolism. 2005; 1: 191\u2013200.","DOI":"10.1016\/j.cmet.2005.01.003"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Galesloot TE, Holewijn S, Kiemeney LA, de Graaf J, Vermeulen SH, Swinkels DW. Serum Hepcidin is Associated with Presence of Plaque in Postmenopausal Women of a General Population. Arteriosclerosis, Thrombosis, and Vascular Biology. 2014; 34: 446\u2013456.","DOI":"10.1161\/ATVBAHA.113.302381"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Malhotra R, Wunderer F, Barnes HJ, Bagchi A, Buswell MD, O\u2019Rourke CD, et al. Hepcidin Deficiency Protects against Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2019; 39: 178\u2013187.","DOI":"10.1161\/ATVBAHA.118.312215"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Lee TS, Shiao MS, Pan CC, Chau LYf. Iron-Deficient Diet Reduces Atherosclerotic Lesions in ApoE-Deficient Mice. Circulation. 1999; 99: 1222\u20131229.","DOI":"10.1161\/01.CIR.99.9.1222"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Vinchi F, Porto G, Simmelbauer A, Altamura S, Passos ST, Garbowski M, et al. Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction. European Heart Journal. 2020; 41: 2681\u20132695.","DOI":"10.1093\/eurheartj\/ehz112"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/23\/5\/10.31083\/j.rcm2305169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T17:56:11Z","timestamp":1732730171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/23\/5\/10.31083\/j.rcm2305169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"alternative-id":["S1530-6550(22)00506-3"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm2305169","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"article-number":"169"}}